A pilot study of the Pathways program to address fear of recurrence and reduce distress among breast cancer survivors.

Authors

null

Edward Kenji Hadeler

University of California, San Francisco, San Francisco, CA

Edward Kenji Hadeler , Emily Claire Wong , Matina Elise Mamounas , Carrie D'andrea , Greg Hicks , Laura Esserman , Michelle Melisko

Organizations

University of California, San Francisco, San Francisco, CA

Research Funding

Other

Background: Breast cancer patients endorse anxiety and fear of recurrence for years after diagnosis. The Pathways for Survivors is a one-day program intended to address this distress by teaching cognitive behavioral strategies that improve self-efficacy, communication, attitude, and coping. The workshop incorporates an evidence-based program developed by authors/researchers Greg Hicks and Rick Foster, which has been adapted for the breast cancer survivorship population. Methods: Patients who had completed their acute phase of care were invited to attend the workshop. Attendees were asked to complete a series of questionnaires either on paper or electronically at baseline, 1 week and 6 weeks following the program and were consented to have their data used for research. Questionnaires included evaluation of program content and moderator quality, as well as measures to assess the impact of the Pathways intervention including the PROMIS Anxiety and Depression Short Forms, and the Acceptance and Action Questionnaire (AAQ-II). Results: Three sessions were held between 9/2015-9/2016. A total of 27 patients participated (6 in the first, 13 in the second, 8 in the third). Mean age of participants was 49 (range 28-65) years old. Race and ethnicity was: 63% White, 11% Asian, 4% Pacific Islander, 11% other, and 15% Hispanic/Latina (total > 100% due to a patient reporting more than one race/ethnicity). The table below summarizes the change in these scores over time. Evaluations showed that patients were extremely satisfied with the program and moderator, receiving average ratings of 9.6/10 and 10/10, respectively. Conclusions: The Pathways workshop was well received and appears to have at least a short-term impact on breast cancer survivors’ anxiety, depression, and psychological flexibility.

Survey TimepointPROMIS
Anxiety
Mean; STD
PROMIS
Anxiety
Range (0-20)
PROMIS
Depression
Mean; STD
PROMIS
Depression
Range (0-20)
AAQ-II
Mean; STD
(7-49)
Baseline (N = 25)10.0 ± 3.04-158.2 ± 3.24-1320.0 ± 9.47
Week 1 (N = 20)7.9 ± 2.94-156.4 ± 3.14-1414.8 ± 7.55
Week 6* (N = 11)8.3 ± 3.54-166.8 ± 2.94-1315.3 ± 9.31

*Week 6 data has not been collected for participants from the 3rd Pathways session.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2017 Cancer Survivorship Symposium

Session Type

Poster Session

Session Title

Poster Session B: Late- and Long-term Effects/Comorbidities, Psychosocial Issues, and Recurrence and Secondary Malignancies

Track

Late- and Long-term Effects/Comorbidities,Psychosocial Issues,Recurrence and Secondary Malignancies

Sub Track

Psychological and Social Well-being

Citation

J Clin Oncol 35, 2017 (suppl 5S; abstr 206)

DOI

10.1200/JCO.2017.35.5_suppl.206

Abstract #

206

Poster Bd #

H10

Abstract Disclosures

Similar Abstracts

First Author: Muna AlKhaifi

First Author: Christy Morrissey

Abstract

2023 ASCO Quality Care Symposium

Demand for oncology visits among low-risk breast cancer survivors.

First Author: Emily H. Douglas

Abstract

2022 ASCO Quality Care Symposium

Oncologist-reported frequency of managing specific long-term and late effects in breast cancer survivors.

First Author: Eden Brauer